Department of Medicinal Chemistry and Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.
J Med Chem. 2023 Jun 22;66(12):8103-8117. doi: 10.1021/acs.jmedchem.3c00432. Epub 2023 Jun 12.
Discovery of pan-antagonist ligands for the melanocortin receptors will help identify the physiological activities controlled by these receptors. The previously reported MC3R/MC4R antagonist Ac-DPhe(pI)-Arg-Nal(2')-Arg-NH was identified herein, for the first time, to possess MC1R and MC5R antagonist activity. Further structure-activity relationship studies probing the second and fourth positions were performed toward the goal of identifying potent melanocortin antagonists. Of the 21 tetrapeptides synthesized, 13 possessed MC1R, MC3R, MC4R, and MC5R antagonist activity. Three tetrapeptides were more than 10-fold selective for the mMC1R, including (LTT1-44, Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH) that possessed 80 nM mMC1R antagonist potency and was at least 40-fold selective over the mMC3R, mMC4R, and mMC5R. Nine tetrapeptides were selective for the mMC4R, including [SSM1-8, Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH] with an mMC4R antagonist potency of 1.6 nM. This compound was administered IT into mice, resulting in a dose-dependent increase in the food intake and demonstrating the in vivo utility of this compound series.
发现黑色素浓缩素受体的泛拮抗剂配体将有助于确定这些受体控制的生理活性。本文首次报道了先前报道的 MC3R/MC4R 拮抗剂 Ac-DPhe(pI)-Arg-Nal(2')-Arg-NH 具有 MC1R 和 MC5R 拮抗剂活性。为了鉴定有效的黑色素浓缩素拮抗剂,进一步对第二和第四位进行了结构活性关系研究。在所合成的 21 个四肽中,有 13 个具有 MC1R、MC3R、MC4R 和 MC5R 拮抗剂活性。三种四肽对 mMC1R 的选择性超过 10 倍,包括 (LTT1-44,Ac-DPhe(pI)-DArg-Nal(2')-Arg-NH),其对 mMC1R 的拮抗效力为 80 nM,对 mMC3R、mMC4R 和 mMC5R 的选择性至少为 40 倍。有 9 个四肽对 mMC4R 具有选择性,包括 [SSM1-8,Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH],其对 mMC4R 的拮抗效力为 1.6 nM。该化合物通过 IT 给药进入小鼠,导致食物摄入量呈剂量依赖性增加,证明了该化合物系列的体内实用性。